Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Independent Bank Corporation (IBCP) were yielding above the 2% mark based on its quarterly dividend (annualized to $0.40), with the stock changing hands as low as $19.98 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return. To illustrate, suppose for example you purchased shares of the iShares Russell 3000 ETF (IWV) back on 5/31/2000 — you would have paid $78.27 per share. Fast forward to 5/31/2012 and each share was worth $77.79 on that date, a loss of $0.48 or 0.6% decrease over twelve years. But now consider that you collected a whopping $10.77 per share in dividends over the same period, increasing your return to 13.15%. Even with dividends reinvested, that only amounts to an average annual total return of about 1.0%; so by comparison collecting a yield above 2% would appear considerably attractive if that yield is sustainable. Independent Bank Corporation (IBCP) is a member of the Russell 3000, giving it special status as one of the largest 3000 companies on the U.S. stock markets.In general, dividend amounts are not always predictable and tend to follow the ups and downs of profitability at each company. In the case of Independent Bank Corporation , looking at the history chart for IBCP below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 2% annual yield. According to the ETF Finder at ETF Channel, IBCP makes up 1.25% of the PowerShares DWA SmallCap Momentum Portfolio ETF ( DWAS) which is trading up by about 0.8% on the day Thursday.
More from Stocks
Europe Stocks Drift Lower, Oil Hits 3-Month High, in Quiet President's Day Trade
European stocks edged higher Monday, although volumes were thin in most markets around the world owing to today's President's Day holiday, as investors continued to key on developments in U.S.-China trade talks.
Ellevest CEO Sallie Krawcheck Has a Message for Wall Street
Sallie Krawcheck sits down with TheStreet to discuss the investing gap, the pay gap and her thoughts on diversity.
Teva Pharmaceuticals CEO Talks "Trough Year", 2020 Turnaround
Teva's CEO explains why 2019 is a trough year for the Israeli pharma company.